Trial Profile
Efficacy of fluticasone/salmeterol therapy measured by forced oscillation technique in patients with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 30 Nov 2015 New trial record